Proxy Advisory Groups Recommend Shareholders of Penwest Pharmaceutical Vote on Tang Capital and Perceptive Life Sciences Master Fund Ltd. GOLD Proxy Card

Published: Jun 14, 2010

SAN DIEGO & NEW YORK--(BUSINESS WIRE)--Tang Capital Partners, LP and Perceptive Life Sciences Master Fund Ltd. today announced that both RiskMetrics Group, Inc. and PROXY Governance, Inc., leading independent proxy advisory and voting firms, have recommended that the shareholders of Penwest Pharmaceuticals Co. (NASDAQ:PPCO) vote on Tang Capital and Perceptive’s GOLD proxy card and NOT on management’s white proxy card.

Back to news